「and n」の検索結果
99件：56～60件目を表示
-
eveloped compound having the development code SJP-0008 was granted by the Ministry of Health, Labor and Welfare (HMLW) on June 19, 2024, as an orphan drug of the Central Retinal Artery Occlusion (CRAO...
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240708.pdf -
Milestones in Our History | About Senju | SENJU Pharmaceutical
sales launched. May Company head office relocated to Kita-ku, Osaka 1972 March Company head office and Osaka branch are relocated to Hiranomachi, Higashi-ku, Osaka 1974 June Fukusaki Plant for manufa...
https://www.senju.co.jp/english/about/history.html -
eveloped compound having the development code SJP-0008 was granted by the Ministry of Health, Labor and Welfare (HMLW) on June 19, 2024, as an orphan drug of the Central Retinal Artery Occlusion (CRAO...
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240708_0.pdf -
Announcement: December 2, 2022 Senju Pharmaceutical Co., Ltd. Launch of Distribution of “MIEr-Blue” and “MIEr-Red” Senju Pharmaceutical Co., Ltd. hereby announces the commercial launch and distributio...
https://www.senju.co.jp/sites/default/files/content_news/2022-11/ENG_20221202.pdf -
Announcement: December 2, 2022 Senju Pharmaceutical Co., Ltd. Launch of Distribution of “MIEr-Blue” and “MIEr-Red” Senju Pharmaceutical Co., Ltd. hereby announces the commercial launch and distributio...
https://www.senju.co.jp/sites/default/files/content_news/2022-11/ENG_20221202_0.pdf